We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Epigenomics AG, a molecular diagnostics company developing tests based on DNA methylation, announced the successful identification of novel candidate biomarkers in lung cancer.
Medical device company NESS Neuromuscular Electrical Stimulation Systems Ltd. announced that it received US Food and Drug Administration (FDA) approval to market its NESS L300 device for moving paralyzed legs in the US.
Avanca Medical Devices, a company founded by UNM physician Dr. Wilmer L. Sibbitt, Jr. in 2004, has been sold to Global Medical Solutions, Ltd. Avanca Medical Devices develops technologies for small medical devices, the most prominent being the Reciprocating Procedure Device, a syringe that can be operated with one hand.
Medical device company nContact Surgical has raised $7.5 million in venture capital to complete clinical trials, and if all goes well, it will gear up to sell its first product.
Power mobility device (PMD) firm representatives are intensifying their challenge to proposed cuts in reimbursement levels by the Centers for Medicare & Medicaid Services (CMS), which are scheduled to take effect Nov. 15.
The FDA is seeking a permanent injunction against Endotec and three of its executives to stop their illegal distribution of unapproved total-joint replacement devices, the agency announced Oct. 6.
If device reprocessors had more legal responsibility for adverse events linked to reused single-use devices (SUDs), the original devicemakers would not have to worry so much about liability when problems arise with the reused devices, an expert says.
Roche Diagnostics signed a letter of intent to negotiate an agreement for the joint development and commercialization of homogeneous fully-automated oral fluid drugs of abuse assays that can run on random access chemistry analyzers with OraSure Technologies, Inc.
Dispelling a stubborn myth, researchers at Johns Hopkins have shown that children with strokes, brain tumors and other cerebrovascular diseases can safely undergo a potentially life-saving brain-mapping test that many doctors have long shunned over concerns for side effects.
Millennium Research Group (MRG), the global authority on medical technology market intelligence, has conducted a detailed and thorough analysis of the transcatheter embolization and occlusion (TEO) device market.